Sign in
Taking people in United StatesNo phase

Donor Bone Marrow Offered to Patients With Blood Cancers or Blood Disorders

Offers donor bone marrow transplant to people with blood cancers or disorders.

Key facts

Who runs it
Ossium Health, Inc.
Where
Birmingham, Columbus, Detroit, Duarte, and Nashville, United StatesSee the 5 sites
Trial code
Registry title
HPC Offered for PRESERVE Expansion
Status
Recruiting
People taking part
10 people, planned
Started
27 Jun 2024
Expected to end
Aug 2029
Type of study
Observational
Treatments tested
  • Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)
Record updated
6 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 12 to 80 whose doctor has decided they can have a donor bone marrow transplant for a blood cancer or blood disorder, and that the possible benefit outweighs the risks.

Age
12 to 80 years
Sex
All sexes can join.
Disease stage
Blood cancers or blood disorders for which the treating doctor has decided on a donor bone marrow transplant.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Patients aged 12-80 may be eligible* to receive bone marrow for transplantation through the Ossium HOPE Program if:
  • Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 80 years old?

Where in United States

  • University of Alabama BirminghamBirmingham, United StatesContact: Mary UnderwoodTaking people
  • The Ohio State University Medical CenterColumbus, United StatesContact: Nicole SzuminskiTaking people
  • Henry Ford HealthDetroit, United StatesContact: Kelly WallsTaking people
  • City of HopeDuarte, United StatesContact: Lindsay PoehlmanTaking people
  • TriStar Centennial Medical centerNashville, United StatesContact: Angela HeineTaking people

About the trial

What the trial wants to find out

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

The group in the trial

  • Ossium HPC, Marrow

    Ossium HPC, Marrow will be provide for infusion on the day of transplant

    Treatment: Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for HOPE Patients With Hematologic Malignancies or Disorders
Plain-language title
Donor Bone Marrow Offered to Patients With Blood Cancers or Blood DisordersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07145411, who can take part
Record updated
6 November 2026